Mason Street Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Mason Street Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,344	Closed	-$498K	–	1533
2019 Q3	$498K	Buy	+7,344	New	+$504K	0.01%	1103

Mason Street Advisors's GHDX Position: Q4 2019 in Review

Mason Street Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 7,344 shares — an estimated $498K sold.

Mason Street Advisors first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $498K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Mason Street Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Mason Street Advisors sold 7,344 Genomic Health, Inc. shares in Q4 2019, an estimated $498K.
Mason Street Advisors first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
Mason Street Advisors's Genomic Health, Inc. position peaked at $498K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Mason Street Advisors's 13F filing for Q4 2019, filed 19 Feb 2020.